In Vitro Diagnostics (IVD) Asia-Pacific Market Opportunities and Forecasts, 2014 - 2020 Published on – 01 March, 2016 | Number of pages : 180 Single User Price: $2850 The research methodology used to estimate and forecast In Vitro Diagnostics (IVD) AsiaPacific Market begins with capturing data on key vendor revenue through the secondary research.
Summary of the Report: The In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. These tests require specialized in vitro diagnostic medical devices. There is high demand for the In Vitro Diagnostics (IVD) Asia-Pacific Market due to the increasing illnesses and diseases among the population in this region.
Click Here To Check Complete Report
Topics Covered in this report : Scope and Regional Forecast of the In Vitro Diagnostics (IVD) Asia-Pacific Market:
The In Vitro Diagnostics (IVD) Asia-Pacific Market is estimated to grow at a CAGR of 6.5% through 2020. Considerable increase in the number of chronic and infectious diseases, growing awareness towards healthcare solutions and technological advancements in healthcare industry largely supplement the growth of this market. The driving factors of the In Vitro Diagnostics (IVD) Asia-Pacific Market are increasing demand for technologically advanced diagnostic devices, rise in GDP and per capita income and rise in disposable incomes facilitate a huge potential through 2020.
China leads the In Vitro Diagnostics (IVD) Asia-Pacific Market, owing to the high demand for testing in outpatient clinics, huge population base and rising medical insurance services by the Chinese government. However, Australia and South Korea hold the significant market share due to the well-supported reimbursement facilities and well-regulated IVD devices.
Segmentation and Key Players of the In Vitro Diagnostics (IVD) Asia-Pacific Market: The In Vitro Diagnostics (IVD) Asia-Pacific Market is segmented into various categories by techniques, by product type, by usability, by application, by end user and by country. By product type: instruments, reagents, data management system hardware/ software and services
By techniques: Immunoassay/Immunochemistry, Clinical Chemistry (Urine chemistry analyzers, Blood gas electrolyte analyzers), Hematology (High throughput analyzers, Medium throughput analyzers and Low throughput analyzers), Coagulation, Point of care, Microbiology (Blood culture, Pathological culture, Identification & antibiotic susceptibility testing and others), Molecular Diagnostics (Infectious diseases, Oncology, Genetic diseases, Blood Screening and others), Whole Blood Glucose and other clinical techniques (Clinical centrifuges, Tissue diagnosis, Sample processors, Flow cytometry and Cytology) By usability: disposable IVD devices, reusable IVD devices By application: infectious diseases, diabetes, cancer/ oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others By end user: hospitals, laboratory, academics, point of care/ self-testing and others
Download Sample Brochure
The key in vitro diagnostic companies in the In Vitro Diagnostics (IVD) Asia-Pacific Market are as follows: • Danaher Corporation • Vela Diagnostics • Abbott Laboratories Inc. • Johnson & Johnson • Siemens Healthcare The In Vitro Diagnostics (IVD) Asia-Pacific Market is a rapidly growing market in the region due to the high population of the region and healthcare advancement. There is high demand for diagnostic techniques and CE IVD equipment through 2020.
Inquiry Before Buying
In Vitro Diagnostics (IVD) Asia-Pacific Market Opportunities and Forecasts, 2014 - 2020 A detailed qualitative analysis of the factors responsible for driving and restraining growth of the In Vitro Diagnostics (IVD) Asia-Pacific Market and future opportunities are provided in the report.
Contact: 1-302-261-5343 sales@marketintelreports.com www.marketintelreports.com
Click here to order a copy of In Vitro Diagnostics (IVD) AsiaPacific 2014-2020 Market Research Report